Dr Aloysious D Aravinthan

Dr Aravinthan is an associate professor and honorary consultant in hepatology. He completed his postgraduate training in hepatology at Cambridge University Hospitals NHS Trust, UK and Toronto General Hospital and University of Toronto, Canada. His doctoral thesis, awarded by the University of Cambridge, focused on the role of hepatocyte senescence in the progression of chronic liver disease. He was awarded the prestigious Sheila Sherlock Research Award by the British Association for the Study of the Liver in 2014 and the Sheila Sherlock Travelling Fellowship by the Royal College of Physicians in 2015. His research continues to focus on the prognostic and therapeutic role of cellular senescence in liver disease, hepatocellular carcinoma, and outcomes following liver transplantation.

Dr Aravinthan is the clinical lead for the Nottingham Primary Liver Cancer (HCC) service.